Douglas Dieterich, MD, discusses AZURE-1 data showing brelovitug responses in chronic hepatitis D continued to improve with treatment beyond Week 24.
Douglas Dieterich, MD
Advertisement
Douglas Dieterich, MD, is a Professor of Medicine, Icahn School of Medicine at Mount Sinai.
Articles by Douglas Dieterich, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
STREAM: Statin Discontinuation Noninferior in Older Adults Without CVD
2
Bepirovirsen Functional Cure Durable Through Week 96 in Chronic Hepatitis B
3
AHA 2026: Intensive Blood Pressure Control Reduces Events After Ischemic Stroke
4
Common Diuretic Linked to Home Blood Pressure Lowering After Stroke
5